Real-World Effectiveness, Adherence, and Persistence among Patients with T2DM Initiating Dulaglutide

被引：0
|
作者：
Mody, Reema
Grabner, Michael
Yu, Maria
Turner, Ralph
Kwan, Anita
York, Whitney
Lando, Laura Fernandez
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1327-P
引用
收藏
页码：A355 / A355
页数：1
相关论文
共 50 条
  • [41] Treatment Persistence and Switch in German Patients with Type 2 Diabetes Mellitus (T2DM) after Initiating Basal Insulin
    Chou, Engels
    Dippel, Franz-Werner
    Chung, Hsing-Wen
    DIABETES, 2014, 63 : A403 - A403
  • [42] Real-World Persistence and Adherence to Crizotinib in over 3800 US Patients
    Rudychev, Igor
    Chioda, Marc
    Veneziano, Greg
    Murray, Bryan
    Horblyuk, Ruslan
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S377 - S378
  • [43] Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective study
    Kenichi Tanaka
    Yosuke Okada
    Akemi Tokutsu
    Yoshiya Tanaka
    Scientific Reports, 12
  • [44] Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective study
    Tanaka, Kenichi
    Okada, Yosuke
    Tokutsu, Akemi
    Tanaka, Yoshiya
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [45] Real-world treatment switching patterns in patients (pts) with type 2 diabetes mellitus (T2DM) on basal insulin (INS)
    Kapustin, J.
    Anderson, J. E.
    Reid, T.
    Rhinehart, A.
    Brunton, S.
    Stewart, J.
    Zhou, W.
    Dex, T.
    Kazemi, M.
    Vlajnic, A.
    Dalal, M.
    DIABETOLOGIA, 2014, 57 : S440 - S440
  • [46] Real-World Outcomes of Patients with Type 2 Diabetes Mellitus (T2DM) Treated with Canagliflozin in a US Managed Care Setting
    Chow, Wing
    Buysman, Erin K.
    Rupnow, Marcia F. T.
    Henk, Henry J.
    DIABETES, 2015, 64 : A347 - A348
  • [47] Nonalcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes Mellitus (T2DM) Patients in India: A Real-World Perspective
    Singh, Vikram Jit
    Singh, Manmohan
    Patidar, Hemant
    DIABETES, 2020, 69
  • [48] Real-World Effectiveness Analysis of Switching From Liraglutide or Dulaglutide to Semaglutide in Patients With Type 2 Diabetes Mellitus: The Retrospective REALISE-DM Study
    Akshay B. Jain
    Steve Kanters
    Reena Khurana
    Jagoda Kissock
    Naomi Severin
    Sara G. Stafford
    Diabetes Therapy, 2021, 12 : 527 - 536
  • [49] Real-World Effectiveness Analysis of Switching From Liraglutide or Dulaglutide to Semaglutide in Patients With Type 2 Diabetes Mellitus: The Retrospective REALISE-DM Study
    Jain, Akshay B.
    Kanters, Steve
    Khurana, Reena
    Kissock, Jagoda
    Severin, Naomi
    Stafford, Sara G.
    DIABETES THERAPY, 2021, 12 (02) : 527 - 536
  • [50] Impact of Diabetes Treatment-Related Attributes on Costs of Type 2 Diabetes (T2DM) Patients in a Real-World Population
    Lee, Yi-Chien
    Meng, Jie
    Casciano, Roman
    Perrin, Allison
    Gultyaev, Dmitry
    Tong, Liyue
    Kitio-Dschassi, Brice
    DIABETES, 2016, 65 : A323 - A323
12345